	Impact of Administration Timing of Immune Checkpoint Inhibitors in Metastatic and Advanced Non-small Cell Lung Cancer: Systematic Review and Updated Meta-Analysis. Am J Ther Khan A, Nasrallah J, Shafi N, Kalininskiy A, Nasir A. PMID: 42912505 [PubMed - as supplied by publisher]
	Effect of Acupuncture for Loss of Appetite in Advanced Lung Cancer Undergoing Immunotherapy: Protocol of a Randomized Controlled Trial. Integr Cancer Ther Fan J, Zhan Y, Chen H, Sun Y, Fang J, Xu Y, Liu Z. PMID: 42912496 [PubMed - indexed for MEDLINE]
	Lung cancer metabolism: a dynamic and adaptive network. Cell Mol Life Sci Gholamhosseinian-Najjar S, Frezza C. PMID: 42911237 [PubMed - indexed for MEDLINE]
	From discovery to clinical implementation: a bibliometric analysis of DNA methylation biomarkers in non-small cell lung cancer, 1999-2025. Epigenomics Li Y, Wu F, Liu W, He X, Chen C. PMID: 42911130 [PubMed - as supplied by publisher]
	Driver Gene Mutations Reprogram Lipid Metabolism in Non-Small Cell Lung Cancer. Cancer Med Lin J, Pang Z, Jiang Z, Li F. PMID: 42910561 [PubMed - indexed for MEDLINE]
	Real-World Comparative Survival Outcomes of First-Line Serplulimab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Single-Center Retrospective Cohort Study. J Cancer Jing Y, Li M, Li S, Zhao Y, Zhou Z, Li X, Wang M. PMID: 42910403 [PubMed]
	Study protocol for the TROG 21.08 VITaL trial: a randomized controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy. Clin Transl Radiat Oncol Vino D SK, Gebski V, Senthi S, Kai C, Jayamanne D, Palma D, Hardcastle N, Byrne HL, Hoover DA, Kipritidis J, Espinoza A, Zwan B, Kaur G, Sawant A, Tahir BA, Mercieca-Bebber R, Shah KK, Bowen A, Cavanagh M, Hunt L, Arulananda S, Ball H, Eikelis N, Moore A, Silvester S, Keall P. PMID: 42910049 [PubMed]
	Beyond immune surveillance: IFN-Î³ and PD-L1 as shapers of tumor plasticity in Non-Small Cell Lung Cancer (NSCLC). Front Immunol Angelicola S, Frascino M, Chillico IC, Michel PLS, Pistone D, Semprini MS, Pittino OM, Ardizzoni A, Alessio NL, Agustoni F, Gelsomino F, Lollini PL, Palladini A. PMID: 42909957 [PubMed - indexed for MEDLINE]
	Short-term outcomes of mini-thoracotomy, multiportal video-assisted thoracic surgery, and multiportal robot-assisted thoracic surgery for complex segmentectomy. J Robot Surg Isaka T, Murata G, Nishina N, Ogata M, Takada I, Kanno C, Nagashima T, Ito H. PMID: 42909739 [PubMed - indexed for MEDLINE]
	Data-driven exploration of occupations and lung cancer risks using regularized regression models. Int J Epidemiol Ge C, Nie J, Portengen L, Olsson A, Schüz J, Ahrens W, Barul C, Behrens T, Brüning T, Caporaso NE, Consonni D, Demers PA, Fabianova E, Fernández-Tardón G, Field JK, Forastiere F, Foretova L, Gustavsson P, Janout V, Jöckel KH, Karrasch S, Kendzia B, Kromhout H, Landi MT, Lissowska J, Mates D, McLaughlin JR, Merletti F, Migliore E, Pándics T, Radoi L, Richiardi L, Schejbalova M, Siemiatycki J, , Wichmann HE, Zaridze D, Straif K, Peters S, Vermeulen R. PMID: 42909464 [PubMed - indexed for MEDLINE]
	Impact of catheter positioning on planned target volume (PTV) coverage and organs at risk (OARs) in high-dose-rate (HDR) endotracheal brachytherapy: a comparative 2D vs 3D study. Int J Med Sci Castellón JN, Cacho IF, Carrizosa ML, Villoslada CI, Morcillo MD, Esteban EC, Bueno PS, Zarrabeitia ZZ, Sanz AP, Pérez NC, Avedillo FSM, Gallego MC, Ortega MA, García MS. PMID: 42909360 [PubMed - indexed for MEDLINE]
	Emerging antibody-drug conjugates in lung cancer: highlights from the 2026 ASCO Annual Meeting. Front Oncol Wang X, Miao J, Bao Y, Wang W, Yan X, Wang M, Shen H. PMID: 42909136 [PubMed]
	Development and internal validation of a predictive model for clinical deterioration in newly diagnosed lung cancer patients based on interpretable machine learning. Front Med (Lausanne) Li H, Li Y, Huang X, Zhang Z, Liu Q, Chen Q. PMID: 42908942 [PubMed]
	Antibody-drug conjugates in advanced small-cell lung cancer: a systematic review and single-arm meta-analysis of later-line monotherapy. Front Immunol Chen X, Li S, Li H. PMID: 42908912 [PubMed - indexed for MEDLINE]
	Clinical characteristics and prognostic analysis of patients with connective tissue disease complicated by non-small cell lung cancer. Am J Cancer Res Zhang G, Ding Q, Zhang L, Jiang M, Luo J, Shen Y, Liu J, Wang Y. PMID: 42908716 [PubMed]
	Perioperative and oncological outcomes of single-port versus two-port thoracoscopic lobectomy for non-small cell lung cancer: a propensity score-matched retrospective study. Am J Cancer Res Li W, Yang X, Hao X, Ke L, Wei B. PMID: 42908704 [PubMed]
	InDuRanS: neoadjuvant immunochemotherapy followed by surgery or definitive chemoradiotherapy and consolidation durvalumab in resectable and borderline resectable stage IIB-IIIA/B non-small-cell lung cancer. Front Oncol Gkika E, Waller CF, Dejonckheere CS, Layer JP, Meiners J, Brossart P, Rodermann E, Schiefer AS, Münter M, Nicolay NH, Grosu AL, Rimner A, Schmidt J, Schmid S. PMID: 42908627 [PubMed]
	Emerging Roles of Gold Nanoparticles in Lung Cancer Diagnosis and Imaging: A Promising yet Underexplored Frontier. Asia Pac J Clin Oncol Sharma S, Chadha VD. PMID: 42908350 [PubMed - as supplied by publisher]
	Developing a prediction model to predict the incidence of metastasis in lung cancer patients using artificial intelligence techniques. BMC Pulm Med Gharabaghi MA, Gholamzadeh M. PMID: 42907991 [PubMed - indexed for MEDLINE]
	Clinical and pathological characteristics, immune microenvironment, and survival analysis of molecular subtypes of surgically resected small cell lung cancer. BMC Cancer Tian J, He J, Tian H, Hou X, Liu D. PMID: 42907953 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162922

Page 1 of 8147



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy